Evidence map›Paper›PMID 35209917›Full record

ArticleOrphanet journal of rare diseases2022

Epidemiology of rare diseases in Brazil: protocol of the Brazilian Rare Diseases Network (RARAS-BRDN).

Têmis Maria Félix, Bibiana Mello de Oliveira, Milena Artifon, Isabelle Carvalho, Filipe Andrade Bernardi, Ida V D Schwartz, Jonas A Saute, Victor E F Ferraz, Angelina X Acosta, Ney Boa Sorte and 2 more

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. The Minimum Data Set for Rare Diseases: Systematic Review.Journal of medical Internet research · 2023
    Pooled it
  2. Clinical and Genetic Spectrum ofNeurology. Genetics · 2026
    Article
  3. Article
  4. Repercussions of Diagnostic Delay in Rare Diseases.Journal of genetic counseling · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Building a National Policy for Rare Disease in Brazil.Journal of community genetics · 2025
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Rare diseases: What rheumatologists need to know?Advances in rheumatology (London, England) · 2024
    Review
  19. Oral Problems in Brazilian Individuals with Rare Genetic Diseases That Affect Skeletal Development.International journal of environmental research and public health · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Têmis Maria FélixMedical Genetics Service, Porto Alegre Clinical Hospital, Ramiro Barcelos St., 2350, Porto Alegre, RS, 90035-903, Brazil. tfelix@hcpa.edu.br.ORCID 0000-0002-8401-6821
Bibiana Mello de OliveiraMedical Genetics Service, Porto Alegre Clinical Hospital, Ramiro Barcelos St., 2350, Porto Alegre, RS, 90035-903, Brazil.
Milena ArtifonMedical Genetics Service, Porto Alegre Clinical Hospital, Ramiro Barcelos St., 2350, Porto Alegre, RS, 90035-903, Brazil.
Isabelle CarvalhoDepartment of Social Medicine, Ribeirão Preto Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
Filipe Andrade BernardiDepartment of Social Medicine, Ribeirão Preto Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
Ida V D SchwartzMedical Genetics Service, Porto Alegre Clinical Hospital, Ramiro Barcelos St., 2350, Porto Alegre, RS, 90035-903, Brazil.
Jonas A SauteMedical Genetics Service, Porto Alegre Clinical Hospital, Ramiro Barcelos St., 2350, Porto Alegre, RS, 90035-903, Brazil.
Victor E F FerrazDepartment of Genetics, Ribeirão Preto Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
Angelina X AcostaDepartment of Pediatrics, Federal University of Bahia, Salvador, Brazil.
Ney Boa SorteDepartment of Pediatrics, Federal University of Bahia, Salvador, Brazil.
Domingos AlvesDepartment of Social Medicine, Ribeirão Preto Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
RARAS Network group
Universidade de São Paulo · BRUniversidade Federal do Rio Grande do Sul · BRUniversidade Federal da Bahia · BRHospital de Clínicas de Porto Alegre · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Brazilian Policy of Comprehensive Care for People with Rare Diseases (BPCCPRD) was established by the Ministry of Health to reduce morbidity and mortality and improve the quality of life of people with rare diseases (RD). Several laboratory tests, most using molecular genetic technologies, have been incorporated by the Brazilian Public Health System, and 18 specialised centres have so far been established at university hospitals (UH) in the capitals of the Southern, Southeastern and Northeastern regions. However, whether the available human and technological resources in these services are appropriate and sufficient to achieve the goals of care established by the BPCCPRD is unknown. Despite great advances in diagnosis, especially due to new technologies and the recent structuring of clinical assessment of RD in Brazil, epidemiological data are lacking and when available, restricted to specific disorders. This position paper summarises the performance of a nationally representative survey on epidemiology, clinical status, and diagnostic and therapeutic resources employed for individuals with genetic and non-genetic RD in Brazil. The Brazilian Rare Disease Network (BRDN) is under development, comprising 40 institutions, including 18 UH, 17 Rare Diseases Reference Services and five Newborn Screening Reference Services. A retrospective study will be initially conducted, followed by a prospective study. The data collection instrument will use a standard protocol with sociodemographic data and clinical and diagnostic aspects according to international ontology. This great collaborative network is the first initiative of a large epidemiological data collection of RD in Latin America, and the results will increase the knowledge of RD in Brazil and help health managers to improve national public policy on RD in Brazil.

Indexed as

Quality of LifeRare DiseasesBrazilHumansInfant, NewbornProspective StudiesRetrospective StudiesEpidemiologyHealthcare systemPublic healthRare diseases

Identifiers

PMID35209917
PMCPMC8867447
OpenAlexW4213440925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.